Multicenter fase III undersøgelse af effekten af præoperativ (neoadjuverende) kemoterapi inden operation med efterfølgende adjuverende kemoterapi ved operabel NSCLC stadie IB, IIA; IIB, og IIIA/T3.
- Conditions
- operable NSCLC.Pts are randomized to receive or not receive two courses of neoadjuvant chemotherapy before surgery
- Registration Number
- EUCTR2006-003503-39-DK
- Lead Sponsor
- Jens Benn Sorensen, Dept. oncology, Finsen Centre/National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
NSCLC
resectable disease
normal organ function
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
abnormal liver-, renal-, or bone marrow function
inability to understand the protocol information
inability to cooperate with the protocoll treatment
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method